Harley-Davidson Finds Local Partner to Make Motorbikes in China

Harley-Davidson Finds Local Partner to Make Motorbikes in China

American motorbike maker Harley-Davidson Motor is joining hands with Chinese counterpart Qianjiang Motorcycle to start selling small-engine motorbikes in China before the end of next year. The firms will develop two Harleys for the Asian markets...

Read more
Oracle up as it beats expectations

Oracle up as it beats expectations

Oracle beat on top and bottom lines. The company saw growth in cloud application revenue. Oracle stock went up as much as 7% on Wednesday after the company reported better-than-expected earnings for the fourth quarter of its 2019 fiscal year...

Read more
Chinese Conba Pharma’s Stocks Rally on Finishing First Hemp Cultivation

Chinese Conba Pharma’s Stocks Rally on Finishing First Hemp Cultivation

The share price of Conba Pharmaceutical’s soared today after the Chinese firm announced it has planted its first crop of industrial hemp. Conba Pharma’s [SHA:600572] share price rose by the daily limit of 10 percent to CNY6.60...

Read more
Gilead Strikes $2.48 Billion Deal with Nurix to Focus on Protein Degradation

Gilead Strikes $2.48 Billion Deal with Nurix to Focus on Protein Degradation

Gilead Sciences and Nurix, based in Forest City, Calif. and San Francisco, respectively, signed a global strategic collaboration deal that could hit $2.48 billion. The focus will be on discovering drugs that use the body’s natural protein control...

Read more
Cellular Bio Starts Phase I China Trial of CD20 CAR-T

Cellular Bio Starts Phase I China Trial of CD20 CAR-T

Cellular Biomedicine, a New York-Shanghai company, has started a China Phase I trial of its CD20 CAR-T candidate in patients who relapsed after CD19 treatment. The patients have either relapsed diffuse large B-cell lymphoma or small B-cell...

Read more
CARsgen Given Green Light for US Trials of BCMA CAR-T Candidate

CARsgen Given Green Light for US Trials of BCMA CAR-T Candidate

CARsgen Therapeutics, a Shanghai CAR-T company, was approved to start US trials of its fully human BCMA (B-Cell Maturation Antigen)-CAR-T therapy for patients with relapsed/refractory multiple myeloma. Four months ago, China’s NMPA approved...

Read more
Trump to launch his 2020 White House bid in Florida as polls show him trailing his Democratic rivals

Trump to launch his 2020 White House bid in Florida as polls show him trailing his Democratic rivals

President Donald Trump officially kicks off his 2020 presidential campaign with a rally in Orlando, Florida, on Tuesday. Trump is trying to hold off a wide Democratic field intent on denying him a second term by winning states like Florida, which...

Read more
Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production

Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production

Intrexon Corporation (Intrexon) (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve quality of life and health of the planet, and Surterra Wellness (Surterra), one of the fastest growing health and wellness...

Read more
Facebook created a ‘gateway drug’ to introduce billions to cryptocurrency, experts say

Facebook created a ‘gateway drug’ to introduce billions to cryptocurrency, experts say

Longtime blockchain technologists say Facebook’s Libra cryptocurrency will introduce billions to the payments technology. But Facebook’s problems with trust and privacy will be large obstacles for Libra to overcome. Blockchain experts on Tuesday...

Read more
BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor

BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor

BeiGene Co.,Ltd (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks...

Read more
CASI Acquires Global Rights To CD19 T-Cell Therapy; Will Make $11.6 Million Investment

CASI Acquires Global Rights To CD19 T-Cell Therapy; Will Make $11.6 Million Investment

CASI Pharma, a US-China company, obtained global rights to an autologous anti-CD19 T-cell therapy developed by Juventas Cell Therapy of Tianjin City, China. Juventas has filed China INDs to test CNCT19 as a treatment for two leukemia and lymphoma...

Read more
Chi-Med’s Surufatinib Meets Survival Endpoint — Trial Stopped Early

Chi-Med’s Surufatinib Meets Survival Endpoint — Trial Stopped Early

Hutchison China MediTech (Chi-Med) will stop its Phase III trial of surufatinib early following positive interim data showing the candidate met its primary endpoint of progression-free survival. The China trial was testing surufatinib in patients...

Read more
Do NOT follow this link or you will be banned from the site!